Via America’s Lawyer: The FDA is again resorting to damage control, now warning the public about Xeljanz, a rheumatoid arthritis drug approved in 2012 that’s been linked to heart disease and cancer. Attorney Sara Papantonio joins Mike Papantonio to explain the dangerous results from recent safety trials. Plus, Johnson & Johnson reserves almost 4 billion dollars to settle tens of […]

The post FDA Warns Arthritis Drug Xeljanz Linked To Cancer & Billions Awarded In Talc Powder Lawsuits appeared first on The Ring of Fire Network.

This post was originally published on The Ring of Fire.